Navigation Links
New anti-viral drug shows promise for dramatic improvement in hepatitis C treatment
Date:8/8/2010

INDIANAPOLIS Adding a direct acting anti-viral drug to the standard treatment regimen for hepatitis C significantly increases the cure rate in the most difficult to treat patients, according to a research report published Monday in the online edition of the journal The Lancet.

The research team, led by Paul Kwo, M.D., of Indiana University School of Medicine, reported that adding the drug nearly doubled the treatment's effectiveness when given for 48 weeks in one treatment arm of the study.

An estimated 3.2 million Americans and 170 million people worldwide are infected with the hepatitis C virus, but many do not know it. In the United States, 70 percent of affected individuals are infected with genotype 1 hepatitis C, the most difficult to treat. Although there may be no symptoms for years, long-term infection can cause cirrhosis and the disease is a leading cause of liver cancer and liver transplantation. Hepatitis C infections occur mainly through transmission of infected blood, such as via injection drug use, and there is no vaccine.

Currently fewer than half of patients with genotype 1 hepatitis C are treated effectively by the standard combination of two drugs, peginterferon alfa-2b plus ribavirin, which is typically given for 48 weeks. The treatment can be difficult for some patients due to anemia and other side effects.

Adding the drug boceprevir increased the cure rate to as high as 75 percent in those who received 48 weeks of the three-drug combination therapy, compared to 38 percent of those in the control group, who received the standard two-drug treatment for 48 weeks, said Dr. Kwo, associate professor of medicine at the IU School of Medicine. The two-year phase 2 trial was conducted at 67 sites with 520 patients in the U.S., Canada and Europe.

In the boceprevir study, known as the SPRINT-1 trial, researchers tested several different options to evaluate the effectiveness of the combination ther
'/>"/>

Contact: Eric Schoch
eschoch@iupui.edu
317-274-7722
Indiana University School of Medicine
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Surgery better than radiation, hormone treatments for some prostate cancer, study shows
2. Women Can Safely Get Pregnant Right After Miscarriage, Study Shows
3. Study shows splitting bowel preparation dosage is most effective cleansing method before colonoscopy
4. Epilepsy Drugs Dont Raise Suicide Risk, Study Shows
5. Iron-regulating protein is strong predictor of breast cancer prognosis, study shows
6. Brain study shows that thinking about God reduces distress -- but only for believers
7. Survey of coastal residents shows Gulf oil spill has significant impact on families
8. Vaccine Shows Some Promise Against Advanced Cancers
9. Women attracted to men in red, research shows
10. Most youth hockey injuries caused by accidents, not checking, UB study shows
11. Most Men With Low-Risk Prostate Cancer Treated Aggressively, Study Shows
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New anti-viral drug shows promise for dramatic improvement in hepatitis C treatment
(Date:8/20/2014)... OR (PRWEB) August 20, 2014 August ... are urged to become educated about eye health and ... examined. One frequently overlooked eye condition that must be ... Sharon Kleyne Hour Power of Water radio show, is ... children increasing exponentially, childhood dry eye is becoming a ...
(Date:8/20/2014)... In a recent article published by ... London (UCL) study showed that dental experts from around ... teeth was the most effective. Analysis of 66 different ... were frequently recommended, but none were favored by a ... experienced cosmetic dentist Dr. Patrick J. Broome, ...
(Date:8/20/2014)... 2014 B. E. Smith, the only ... has been retained to lead a national chief ... System in Hermiston, Ore. The top executive search ... has recently placed more than 900 healthcare executives into ... a progressive, not-for-profit healthcare organization serving a population of ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 Oxnard ... founder of the Anacapa Dental Art Institute, is presenting ... Dr. Jivraj will be speaking on All-on-4 dental ... Aspects of Graft Less Solutions” at 12:40 p.m. Sept. ... in Vancouver, British Columbia, Canada. , “The All-on-4 procedure ...
(Date:8/20/2014)... Washington, DC (PRWEB) August 20, 2014 ... Got Heart, Give Hope® Celebration to be hosted in ... Army and Navy Club. This signature event honors the ... the families of the fallen. Proceeds from the Got ... Warriors®, a national nonprofit dedicated to restoring a sense ...
Breaking Medicine News(10 mins):Health News:August is Children’s Eye Health Month, Exams Must Check for Pediatric Dry Eye 2Health News:August is Children’s Eye Health Month, Exams Must Check for Pediatric Dry Eye 3Health News:Ending Confusion About the Best Way to Brush Teeth 2Health News:Ending Confusion About the Best Way to Brush Teeth 3Health News:Good Shepherd Health Care System Retains B. E. Smith to Recruit New COO 2Health News:Good Shepherd Health Care System Retains B. E. Smith to Recruit New COO 3Health News:Internationally Known Oxnard Dentist to Speak at Conference in Vancouver 2Health News:Internationally Known Oxnard Dentist to Speak at Conference in Vancouver 3Health News:Hope For The Warriors Announces Got Heart, Give Hope Celebration in Washington, DC 2
... MENLO PARK, Calif., Oct. 23 SRI International, ... today that Dr. Elizabeth Shriberg, a senior researcher ... has been named a Fellow of the International ... at Interspeech 2009 in Brighton, England, recognizes significant ...
... SILVER SPRING, Md., Oct. 23 The U.S. Food ... a request from the U.S. Centers for Disease Control ... (EUA) for the investigational antiviral drug peramivir intravenous (IV) ... suspected 2009 H1N1 influenza infection who are admitted to ...
... International Dairy Foods Association applauded Agriculture Secretary Tom Vilsack ... offering more low fat milk and dairy products in ... improve the quality of school meals, one of the ... outlined the Obama Administration,s agenda for Child Nutrition Act ...
... Singer/Songwriter Patti Austin Headline Annual Andrus Awards Gala ... leadership in communication , LAS VEGAS, Oct. 24 ... to acclaimed television pioneer Norman Lear at a celebration ... and expo. Lear, creator of shows including " All in the ...
... Surgery 2009 News Briefs are designed to keep you ... at the annual meeting of the American Society of ... briefs are embargoed until the date/time they are presented. ... for media registration, or to arrange interviews with presenters, ...
... that injection sting is excessive disputed in U.S. study , ... that injections of the human papillomavirus (HPV) vaccine are especially ... more than any other shots. , Public health officials worried ... getting the vaccine, which protects against a virus that can ...
Cached Medicine News:Health News:SRI International Researcher Receives International Speech Communication Association (ISCA) Fellow Award 2Health News:SRI International Researcher Receives International Speech Communication Association (ISCA) Fellow Award 3Health News:FDA Authorizes Emergency Use of Intravenous Antiviral Peramivir for 2009 H1N1 Influenza for Certain Patients, Settings 2Health News:IDFA Supports Obama Administration's Commitment to Encourage Schools to Provide More Low Fat Milk and Dairy Products in Schools 2Health News:Legendary TV Producer Norman Lear Receives AARP's Highest Honor 2Health News:Legendary TV Producer Norman Lear Receives AARP's Highest Honor 3Health News:Plastic Surgery 2009 news briefs 2Health News:Plastic Surgery 2009 news briefs 3Health News:Plastic Surgery 2009 news briefs 4Health News:Plastic Surgery 2009 news briefs 5Health News:Plastic Surgery 2009 news briefs 6Health News:HPV Vaccine No More Painful Than Other Shots 2
(Date:8/20/2014)... , Aug. 20, 2014  Quantum Materials ... diverse sets of patent families from Bayer Technology Services ... driver for Bayer AG of Leverkusen, ... acquired provide broad intellectual property protection for advances ... high-volume quantum dot (QD) manufacturing. In addition, the ...
(Date:8/20/2014)... MUMBAI , August 20, 2014 ... owned subsidiary of Glenmark Pharmaceuticals Limited India (GPL), ... studies of a novel clinical development candidate, GBR ... discovered and developed by the Glenmark Biologics Research ... . GBR 1302 is based on Glenmark,s ...
(Date:8/20/2014)... 20, 2014 Phase I Trial ... US  KalVista Pharmaceuticals ("KalVista"), an ophthalmology company ... announces that it has begun a Phase I, First ... KVD001, for the treatment of DME. The study,s Principal ... Eye Institute, Joslin Diabetes Center; Harvard Medical School Department ...
Breaking Medicine Technology:Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 2Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 3Quantum Materials Acquires Bayer Technology Services Quantum Dot Manufacturing and Quantum Dot Solar Cell Patents 4Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody 2Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody 3KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 2KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 3KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 4
... to Differentiate Squamous From, Non-Squamous Non-Small Cell Lung Cancer (NSCLC), Classifying Squamous Cell, ... ... Percent., Accurate Diagnosis is Important for Guiding ... Rates of Severe or Fatal Hemorrhage in Patients With Squamous NSCLC ...
... California, April 3 ,Results of an independent ... the first clinically proven non-invasive solution,for fat ... focused,ultrasound will be presented at the American ... on April 4, 2008 in Kissimmee, Florida. ...
Cached Medicine Technology:Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica 2Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica 3Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica 4Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica 5Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica 6Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica 7UltraShape(R) Non-Invasive Fat Reduction and Body Contouring Clinical Study Results Featured at American Society for Laser Medicine and Surgery Meeting 2UltraShape(R) Non-Invasive Fat Reduction and Body Contouring Clinical Study Results Featured at American Society for Laser Medicine and Surgery Meeting 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: